AI in Life Sciences: What the Industry Is Really Saying – The Pulse on Adoption, Opportunities, and Impact
Artificial Intelligence is moving beyond experimentation and becoming a practical tool for improving operations across the life sciences industry. Organizations are increasingly focused on applying AI to solve real business challenges, improve efficiency, strengthen compliance, and support better decision-making.

To better understand how organizations are adopting AI, Axendia surveyed 194 life sciences executives, decision-makers, and industry professionals for our latest market research report, AI in Life Sciences: What the Industry Is Really Saying – The Pulse on Adoption, Opportunities, and Impact. With more than half of respondents holding executive or decision-making positions, the findings provide a unique perspective on both strategic priorities AND operational realities across the industry.
The research reveals growing momentum behind AI adoption, with organizations looking to improve efficiency, reduce cycle times, strengthen compliance, and support more consistent decision-making. At the same time, the findings highlight ongoing challenges related to data readiness, governance, integration, and regulatory alignment.
Not all organizations are moving at the same pace. The research suggests that approximately 20% of organizations are innovators, actively scaling AI beyond pilot programs, while 60% are followers, evaluating use cases and experimenting with deployment strategies. The remaining 20% are laggards, with limited or no near-term adoption plans. Differences in data readiness, governance, and organizational maturity continue to separate leaders from those still in the early stages of adoption.
The report also identifies key areas organizations should prioritize as they advance their AI initiatives, including governance, data readiness, operational alignment, workforce capabilities, human oversight, and scalability.
Artificial Intelligence is moving beyond experimentation and becoming a practical tool for improving operations across the life sciences industry. Organizations are increasingly focused on applying AI to solve real business challenges, improve efficiency, strengthen compliance, and support better decision-making.
The message from the industry is clear:
AI holds significant promise, but realizing its full potential will require more than technology alone. Success will depend on an organization’s ability to build the foundations necessary to operationalize AI at scale.
–Axendia
Download the full report to explore the findings, industry perspectives, adoption trends, challenges, opportunities, and recommendations shaping the future of AI in life sciences.

Will you be the disruptor or the disrupted? What steps is your organization taking to prepare for the future? Let’s continue the conversation!
Interested in a deeper dive on any of the topics we discussed? Contact us to schedule a briefing!
Axendia AI Related Content:

Stay Connected with Axendia!
Stay at the forefront of innovation and technology in life sciences, healthcare, and space-enabled research by connecting with Axendia.
- Follow us on LinkedIn: Join our professional network and stay updated on the latest insights, trends, and case studies. Connect with Axendia on LinkedIn
- Subscribe to Our Updates: Get exclusive insights and thought leadership articles delivered straight to your inbox. Sign up for our newsletter
- Share Your Thoughts: We’d love to hear from you! Contact us to discuss your ideas, challenges, or opportunities. Email Axendia
Let’s drive innovation together—connect with us today!
Ready to unlock new opportunities and drive success? Click on this link to schedule an Analyst Inquiry on this topic.
The opinions and analysis expressed in this post reflect the judgment of Axendia at the time of publication and are subject to change without notice. Information contained in this post is current as of publication date. Information cited is not warranted by Axendia but has been obtained through a valid research methodology. This post is not intended to endorse any company or product and should not be attributed as such.


